Here’s what we’ll cover in this blog post:
- The hidden bias in women’s research and care
- Do women age differently from men?
- How to tailor longevity strategies for women
We’ve seen extraordinary breakthroughs in health and medicine, from wearable technologies that monitor vital signs in real time to advanced diagnostics, metabolic therapeutics, and longevity interventions that promise to transform how we prevent, detect, and treat disease.
But behind these scientific breakthroughs is an uncomfortable truth: for decades, women have been an afterthought in biomedical research. It shows in their medical care, how often their symptoms are dismissed, and their increased risk for disease.
The Hidden Bias in Research and Care
Until 1993, it was legal, in fact standard, for most drug trials to exclude women entirely.
Why? Because menstrual cycles “complicated” data collection, and pharmaceutical companies didn’t want hormonal fluctuations to “impact” results.
The result is that everything from dosing guidelines to side-effect profiles to diagnostic thresholds was built for men, then simply copied and pasted to women. Consider this:
- 78% of Americans with autoimmune disease are women, yet animal studies using only males outnumber studies that include females by 5x.
- Women are twice as likely to develop Alzheimers, with 2/3 of Alzheimer’s patients being women, yet 66% of neuroscience research animals are male or unreported sex.
- Cardiovascular disease remains the #1 killer of women in the U.S., but only 1/3 of clinical trial participants are female.
- It wasn’t mandated that both sexes be included in preclinical research until 2016.
When biology is ignored, inequity compounds. Women’s heart attacks present differently, with fatigue, shortness of breath, and disrupted sleep. Yet these symptoms are often dismissed as stress or natural symptoms of menopause.
We call this a data gap, but really, it’s a form of systemic neglect.
Do Women Age Differently Than Men?
Yes.
Women live longer than men by an average of five years. But those extra years often come at the cost of poorer healthspan: more frailty, pain, and higher incidence of Alzheimer’s, osteoporosis, and autoimmune diseases.
A Mckinsey Health Institute analysis recently found that women spend 25% more time in poor health than men.
Why? The 3 B’s: Biology. Behavior. And Bias.
The ovaries are one of the first organs to show signs of accelerated aging, decades before other organs, and this early decline sets off systemic ripples: loss of estrogen, mitochondrial decline, immune dysfunction, and accelerated aging across tissues.
Menopause is more than reproductive transition; it’s the single biggest accelerator of female biological aging.
And yet, most longevity research has historically focused on males. When both sexes are studied, findings often differ:
- Rapamycin tends to extend lifespan more robustly in female mice, and in the double blind placebo controlled PEARL study of Rapamycin for longevity, women experienced significant improvements in pain and muscle mass at low doses of Rapamycin while men did not.
- Canagliflozin appears more effective in males at the tested doses.
- Even caloric restriction and intermittent fasting elicit different metabolic signatures across sexes.
Why Women’s Longevity Strategies Must Be Different
Longevity is about tailoring interventions to your biological profile, and for women, that means accounting for sex-specific vulnerabilities and strengths.
Musculoskeletal health
Following menopause, women lose muscle and bone at a faster rate. Strength training and adequate protein (1.0–1.2 g per pound of bodyweight per day) are non-negotiable. Think of it as anti-frailty medicine.
Cardiometabolic health
Heart disease risk rises sharply after menopause. Interventions like statins, Glutathione, or low-dose Tadalafil may have outsized benefits if used proactively.
Cognitive health
Women face a 2x higher Alzheimer’s risk, not merely because they live longer, but likely due to the hormonal shifts and inflammatory cascades of menopause. Protecting sleep, reducing insulin resistance, and considering hormone replacement as a rule can make a huge impact.
Lifestyle & oxidative stress:
Women disproportionately shoulder chronic stress and sleep disruption due to both biological differences and societal pressures. Both are potent drivers of oxidative stress and accelerantors of biological aging. Empathy and support from clinicians and loved ones, consistent circadian rhythms, a cool dark sleep environment (< 65 °F), and stress-lowering habits are core elements of longevity.
A Call to Action
The era of one-size-fits-all medicine is over.
Women deserve clinicians and care models that acknowledge sex as a fundamental biological variable, not a footnote.
That means asking different questions, measuring different biomarkers, and designing interventions that honor women’s unique physiology across the lifespan.
Behind the science lies a simple truth: women’s health is half of human biology. The longer we keep women’s research in our blind spot, the further “longevity for all” remains out of reach. If you’re interested in learning more about your unique biology, risk factors, and how you can take a more proactive approach to your longevity, take our free longevity quiz and explore our longevity products.
–
Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.